
Abstract
Cardiac myxomas usually develop in the atria and consist of an acid-mucopolysaccharide-rich myxoid matrix with polygonal stromal cells scattered throughout. These human benign tumours are a valuable research model because of the rarity of cardiac tumours, their clinical presentation and uncertain origin. Here, we assessed whether multipotent cardiac stem/progenitor cells (CSCs) give rise to atrial myxoma tissue.
Twenty-three myxomas were collected and analysed for the presence of multipotent CSCs. We detected myxoma cells positive for c-kit (c-kitpos) but very rare Isl-1 positive cells. Most of the c-kitpos cells were blood lineage-committed CD45pos/CD31pos cells. However, c-kitpos/CD45neg/CD31neg cardiac myxoma cells expressed stemness and cardiac progenitor cell transcription factors. Approximately ≤10% of the c-kitpos/CD45neg/CD31neg myxoma cells also expressed calretinin, a characteristic of myxoma stromal cells.
Myxoma-derived c-kitpos/CD45neg/CD31neg CSCs fulfill the criteria expected of atrial myxoma-initiating stem cells. The transcriptome of these cells indicates that they belong to or are derived from the same lineage as the atrial multipotent c-kitpos/CD45neg/CD31neg CSCs. Taken together the data presented here suggest that human myxomas could be the first-described CSC-related human heart disease.
Contributors

Mariangela Scalise
Author

Michele Torella
Author

Fabiola Marino
Author

Maria Ravo
Author

Giorgio Giurato
Author

Carla Vicinanza
Author

Eleonora Cianflone
Author

Teresa Mancuso
Author

Iolanda Aquila
Author

Luca Salerno
Author

Giovanni Nassa
Author

Valter Agosti
Author

Antonella De Angelis
Author

Konrad Urbanek
Author

Liberato Berrino
Author

Pierangelo Veltri
Author

Donatella Paolino
Author

Pasquale Mastroroberto
Author

Marisa De Feo
Author

Giuseppe Viglietto
Author

Alessandro Weisz
Author

Bernardo Nadal-Ginard
Author

Georgina M Ellison-Hughes
Author
King's College London London , United Kingdom of Great Britain & Northern Ireland
